NI201100161A -
COMPOSITIONS OF PROPANE-1-SULPHONIC ACID {3 - [5 - (4-CHLORO-PHENYL) - 1H-PYRROLO [2, 3-b] - PYRIDINE-3-CARBONYL] - 2, 4-DIFLUORO-PHENYL} -AMIDE AND THE USE OF THE SAME
- Google Patents
COMPOSITIONS OF PROPANE-1-SULPHONIC ACID {3 - [5 - (4-CHLORO-PHENYL) - 1H-PYRROLO [2, 3-b] - PYRIDINE-3-CARBONYL] - 2, 4-DIFLUORO-PHENYL} -AMIDE AND THE USE OF THE SAME
Info
Publication number
NI201100161A
NI201100161ANI201100161ANI201100161ANI201100161ANI 201100161 ANI201100161 ANI 201100161ANI 201100161 ANI201100161 ANI 201100161ANI 201100161 ANI201100161 ANI 201100161ANI 201100161 ANI201100161 ANI 201100161A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La RochefiledCriticalHoffmann La Roche
Publication of NI201100161ApublicationCriticalpatent/NI201100161A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Nitrogen Condensed Heterocyclic Rings
(AREA)
Abstract
Se proporcionan dispersiones de sólidos, complejos moleculares sólidos, sales y polimorfas cristalinas que involucran el ácido propano - 1 - sulfónico { 3 - [5 - (4 - cloro - fenil) - 1H - pirrolo [2, 3-b] - piridina - 3 - carbonil] - 2, 4 - difluoro - fenil} - amida.Dispersions of solids, solid molecular complexes, salts and crystalline polymorphs are provided involving propane-1-sulfonic acid {3 - [5 - (4-chloro-phenyl) -1H-pyrrolo [2, 3-b] -pyridine - 3-carbonyl] -2, 4-difluoro-phenyl} -amide.
NI201100161A2009-04-032011-08-22
COMPOSITIONS OF PROPANE-1-SULPHONIC ACID {3 - [5 - (4-CHLORO-PHENYL) - 1H-PYRROLO [2, 3-b] - PYRIDINE-3-CARBONYL] - 2, 4-DIFLUORO-PHENYL} -AMIDE AND THE USE OF THE SAME
NI201100161A
(en)
COMPOSITIONS OF PROPANE-1-SULPHONIC ACID {3 - [5 - (4-CHLORO-PHENYL) - 1H-PYRROLO [2, 3-b] - PYRIDINE-3-CARBONYL] - 2, 4-DIFLUORO-PHENYL} -AMIDE AND THE USE OF THE SAME
PROPANE-1-SULPHONIC ACID COMPOSITIONS {3- [5- (4-CHLORINE-PHENYL) -1H-PIRROLO [2,3-b] -PIRIDINA-3-CARBONIL] -2,4-DIFLUORO-PHENIL} -AMIDA AND THE USE OF THE SAME
COMPOUNDS DERIVED FROM IMIDAZO [1,2,3-IJ] -1,8-NAFTIRIDIN-4,9-DIONA; INTERMEDIARY COMPOUNDS; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF BACTERIAL INFECTIONS.
Compounds derived from imidazo [1,2-a] pyridine; preparation procedure; pharmaceutical composition; intermediate compounds; and use in the treatment of cancer.
Anhydrous crystalline form of {(s) -3- [6- (6-methoxy-5-methyl-pyridin-3-yl) -5,6,7,8-tetrahydro-pyrido [4,3-d] pyrimidin- 4-yloxy] -pyrrolidin-1-yl} - (tetrahydro-pyran-4-yl) -methanone, salts thereof; pharmaceutical composition; pharmaceutical combination; use in the treatment of autoimmune, inflammatory, allergic disorders, transplant rejection, among others.
COMPOSITIONS OF PROPANE-1-SULPHONIC ACID {3 - [5 - (4-CHLORO-PHENYL) - 1H-PYRROLO [2, 3-b] - PYRIDINE-3-CARBONYL] - 2, 4-DIFLUORO-PHENYL} -AMIDE AND THE USE OF THE SAME
PROPANE ACID COMPOSITIONS -1-SULPHONIC {3- [5- (4-CHLORINE-PHENYL) -11H-PIRROLO [2,3-B] -PIRIDINA-3-CARBONIL] -2,4 DIFLUORO-PHENYL] -AMIDE AND THE USE OF THE SAME
Compounds derived from 3- (n-heterocyclyl) -pyrrolidin-phenyloxazolidinones; preparation procedure; pharmaceutical composition; and use of the compound for the treatment of bacterial infections
Compounds derived from 3-cyano-pyrrolidine-phenyl-oxazolidinones; preparation procedure; pharmaceutical composition; and use in the treatment of bacterial infections.